Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Inventory Average (2016 - 2025)

Historic Inventory Average for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $933.9 million.

  • Resmed's Inventory Average rose 376.46% to $933.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $933.9 million, marking a year-over-year increase of 376.46%. This contributed to the annual value of $875.0 million for FY2025, which is 386.21% down from last year.
  • According to the latest figures from Q4 2025, Resmed's Inventory Average is $933.9 million, which was up 376.46% from $936.8 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Inventory Average peaked at $1.0 billion during Q2 2023, and registered a low of $470.5 million during Q2 2021.
  • Its 5-year average for Inventory Average is $804.5 million, with a median of $876.9 million in 2024.
  • In the last 5 years, Resmed's Inventory Average soared by 6871.35% in 2022 and then crashed by 1779.61% in 2024.
  • Quarter analysis of 5 years shows Resmed's Inventory Average stood at $549.4 million in 2021, then skyrocketed by 68.71% to $926.9 million in 2022, then rose by 2.03% to $945.7 million in 2023, then dropped by 4.83% to $900.0 million in 2024, then rose by 3.76% to $933.9 million in 2025.
  • Its Inventory Average was $933.9 million in Q4 2025, compared to $936.8 million in Q3 2025 and $895.2 million in Q2 2025.